These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21848287)

  • 1. Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4.
    Gau B; Garai K; Frieden C; Gross ML
    Biochemistry; 2011 Sep; 50(38):8117-26. PubMed ID: 21848287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.
    Chetty PS; Mayne L; Lund-Katz S; Englander SW; Phillips MC
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):968-973. PubMed ID: 28096372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.
    Ray A; Ahalawat N; Mondal J
    Biophys J; 2017 Dec; 113(12):2682-2694. PubMed ID: 29262361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.
    Frieden C; Wang H; Ho CMW
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6292-6297. PubMed ID: 28559318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerning the structure of apoE.
    Frieden C; Garai K
    Protein Sci; 2013 Dec; 22(12):1820-5. PubMed ID: 24115173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease.
    Frieden C; Garai K
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8913-8. PubMed ID: 22615372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
    Mahley RW
    J Mol Med (Berl); 2016 Jul; 94(7):739-46. PubMed ID: 27277824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical cross-linking/mass spectrometry maps the amyloid β peptide binding region on both apolipoprotein E domains.
    Deroo S; Stengel F; Mohammadi A; Henry N; Hubin E; Krammer EM; Aebersold R; Raussens V
    ACS Chem Biol; 2015 Apr; 10(4):1010-6. PubMed ID: 25546376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.
    Hirtz C; Vialaret J; Nouadje G; Schraen S; Benlian P; Mary S; Philibert P; Tiers L; Bros P; Delaby C; Gabelle A; Lehmann S
    Clin Chim Acta; 2016 Feb; 454():33-8. PubMed ID: 26707914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3.
    Tran TN; Kim SH; Gallo C; Amaya M; Kyees J; Narayanaswami V
    Arch Biochem Biophys; 2013 Jan; 529(1):18-25. PubMed ID: 23103361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of apolipoprotein E3/E4 heteromerization.
    Tu KH; Abhari D; Narayanaswami V
    FEBS J; 2019 May; 286(10):1986-1998. PubMed ID: 30802357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR.
    Garai K; Mustafi SM; Baban B; Frieden C
    Protein Sci; 2010 Jan; 19(1):66-74. PubMed ID: 19904741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosylation of ApoE in Alzheimer's disease.
    Abrams AJ; Farooq A; Wang G
    Biochemistry; 2011 May; 50(17):3405-7. PubMed ID: 21443265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association−dissociation behavior of the ApoE proteins: kinetic and equilibrium studies.
    Garai K; Frieden C
    Biochemistry; 2010 Nov; 49(44):9533-41. PubMed ID: 20923231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.
    Begcevic Brkovic I; Zöhrer B; Scholz M; Reinicke M; Dittrich J; Kamalsada S; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Löffler M; Riedel-Heller SG; Ceglarek U
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different isoforms of apoE on aggregation of the α-synuclein protein implicated in Parkinson's disease.
    Emamzadeh FN; Aojula H; McHugh PC; Allsop D
    Neurosci Lett; 2016 Apr; 618():146-151. PubMed ID: 26921451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of APOE isoforms and the association between APOE E3 and E4 with migraine in the Australian Caucasian population.
    Stuart S; Donges B; Murrell M; Haupt LM; Lea RA; Griffiths LR
    Neuroreport; 2013 Jul; 24(10):499-503. PubMed ID: 23660682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.
    Drosatos K; Kypreos KE; Zannis VI
    Biochemistry; 2007 Aug; 46(33):9645-53. PubMed ID: 17655277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.